A clinical trial is underway to study ischemic optic neuropathy. Although the disease is not common, it has a devastating course and there is currently no treatment for it. The main symptom of the disease is the acute loss of vision in one eye. There are no age limits, but most patients are between the ages of 55 and 65. The study, conducted by neurophthalmologists Marjorie Murphy, MD, and Arthur Geltzer, MD, will evaluate the natural course of the disease using interference imaging and will test whether a new medication can protect the optic nerve.
Patients involved in the study can continue to be treated by their own physicians.
By using this website, you accept the terms of our user agreement . Please read it.